Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Carboplatin Injection
Status: Currently in Shortage
»Date first posted:
04/28/2023
»Therapeutic Categories: Oncology
Accord Healthcare Inc. (Reverified 06/22/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34) | Unavailable | Estimated recovery: TBD; NDC is non-exempt | Requirements related to complying with good manufacturing practices |
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) | Unavailable | Estimated recovery: TBD; NDC is non-exempt | Requirements related to complying with good manufacturing practices |
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
Avyxa Pharma, LLC (Reverified 07/15/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08) | Available | ||
| Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50) | Available |
Eugia US LLC (Revised 07/02/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) | Unavailable | Estimated recovery: TBD; Check wholesalers for inventory | Demand increase for the drug |
| Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) | Unavailable | Estimated recovery: TBD; Check wholesalers for inventory | Demand increase for the drug |
Fresenius Kabi USA, LLC (Reverified 06/17/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60) | Unavailable | Next release July 2026. Check wholesalers for inventory. | Delay in shipping of the drug |
Gland Pharma Limited (Reverified 06/12/2026)
Company Contact Information:
Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01) | Unavailable | Discontinued; Distributed by BPI Labs, LLC | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01) | Limited Availability | Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC | Demand increase for the drug |
| Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01) | Limited Availability | Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC | Demand increase for the drug |
| Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01) | Limited Availability | Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC | Demand increase for the drug |
Hospira, Inc., a Pfizer Company (Revised 07/10/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18) | Limited Availability | Limited Supply Available. Next Delivery: July 2026; Estimated Recovery: September 2026 | Demand increase for the drug |
| Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18) | Limited Availability | Limited Supply Available. Next Delivery: July 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22) | Limited Availability | Limited Supply Available. Next Delivery: July 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50) | Unavailable | Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05) | Limited Availability | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
| Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56) | Unavailable | Next Delivery: July 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
| Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05) | Limited Availability | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
Teva Pharmaceuticals USA, Inc. (Revised 07/06/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01) | Limited Availability | Estimated recovery: December 2026 | Delay in shipping of the drug |
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01) | Limited Availability | Estimated recovery: September 2026 | Delay in shipping of the drug |
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01) | Limited Availability | Estimated recovery: September 2026 | Delay in shipping of the drug |
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01) | Available |
Teyro Labs (Reverified 07/15/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) | Unavailable | Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) | Unavailable | Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) | Unavailable | Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) | Unavailable | Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |